Virus Dataset Sample Info

> Dataset: 26890489 Search Result


Summary
Item Summary
Project 26890489
Virus Name HBV
Sample Number 9
Disease HBV/HIV co_infection
Country South African
Data Link https://www.ncbi.nlm.nih.gov/nuccore/?term=KT347087:KT347092[pacc]
https://www.ncbi.nlm.nih.gov/nuccore/?term=GQ184323
https://www.ncbi.nlm.nih.gov/nuccore/?term=GQ184326
https://www.ncbi.nlm.nih.gov/nuccore/?term=GQ167301

Sample
ID Sample ID Age Gender Origin Detail
1 ZADGM3 30 F South African View
2 ZADGM4 36 F South African View
3 ZADGMTMG 40 M South African View
4 ZADGM265 23 F South African View
5 ZADGM285 28 F South African View
6 ZADGMTK 39 F South African View
7 ZADGM1121 55 M South African View
8 ZADGM501 60 M South African View
9 ZADGM452 50 M South African View

Literature
Item Summary
PMID 26890489
Title Complete genome analysis of hepatitis B virus in human immunodeficiency virus infected and uninfected South Africans.
Abstract Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infections are highly endemic in South Africa. Data on the complete genome sequences of HBV in HIV-positive patients in South Africa are scanty. This study characterized the complete HBV genome isolated from both HIV-positive and negative patients at the Dr George Mukhari Academic Hospital (DGMAH), Pretoria. Serum samples from nine (five HIV-positive and four HIV-negative) patients attending the DGMAH from 2007 to 2011 were serologically tested, amplified, and sequenced for complete genome. Phylogenetic tree was constructed using MEGA6.0. Mutations were analyzed by comparing the sequences with genotype-matched GenBank references. Eight patients were HBsAg positive, with only one from the HIV positive group being negative. Phylogenetic analysis of the complete genome sequences classified them into five genotypes; A1 (n = 4), A2 (n = 1), C1 (n = 2), D1 (n = 1), and D3 (n = 1). Deletions up to 35 nucleotides in length were identified in this study. No drug resistance mutations were identified in the P ORF, while the L217R mutation was identified in one subgenotype A2 sequence. The double (A1762T/G1764A) and triple (T1753C/A1762T/G1764A) mutations in the Basal core promoter were identified in four and two sequences, respectively. In the core region, mutation G1888A was identified in four of the subgenotype A1 sequences. In conclusion, this study has added to the limited South African data on HBV genotypes and mutations in HBV/HIV co-infected and HBV mono-infected patients, based on complete HBV genome analysis. Subgenotype A1 was predominant, and no drug-resistant mutants were detected in the study. J. Med. Virol. 88:1560-1566, 2016. (c) 2016 Wiley Periodicals, Inc.